Your browser doesn't support javascript.
loading
Oral histone deacetylase inhibitor tucidinostat (HBI-8000) in patients with relapsed or refractory adult T-cell leukemia/lymphoma: Phase IIb results.
Utsunomiya, Atae; Izutsu, Koji; Jo, Tatsuro; Yoshida, Shinichiro; Tsukasaki, Kunihiro; Ando, Kiyoshi; Choi, Ilseung; Imaizumi, Yoshitaka; Kato, Koji; Kurosawa, Mitsutoshi; Kusumoto, Shigeru; Miyagi, Takashi; Ohtsuka, Eiichi; Sasaki, Osamu; Shibayama, Hirohiko; Shimoda, Kazuya; Takamatsu, Yasushi; Takano, Kuniko; Yonekura, Kentaro; Makita, Shinichi; Taguchi, Jun; Gillings, Mireille; Onogi, Hiroshi; Tobinai, Kensei.
Afiliação
  • Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Jo T; Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Yoshida S; Department of Hematology, National Hospital Organization Nagasaki Medical Center, Japan.
  • Tsukasaki K; Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Ando K; Department of Hematology/Oncology, Tokai University Hospital, Kanagawa, Japan.
  • Choi I; Department of Hematology, NHO Kyushu Cancer Center, Fukuoka, Japan.
  • Imaizumi Y; Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan.
  • Kato K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan.
  • Kurosawa M; Department of Hematology, Hokkaido Cancer Center, Sapporo, Japan.
  • Kusumoto S; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Aichi, Japan.
  • Miyagi T; Department of Hematology, Heartlife Hospital, Okinawa, Japan.
  • Ohtsuka E; Department of Hematology, Oita Prefectural Hospital, Oita, Japan.
  • Sasaki O; Division of Hematology, Miyagi Cancer Center, Miyagi, Japan.
  • Shibayama H; Department of Hematology and Oncology, Osaka University Hospital, Suita, Japan.
  • Shimoda K; Division of Hematology, Diabetes and Endocrinology, Department of Internal Medicine, University of Miyazaki, Miyazaki, Japan.
  • Takamatsu Y; Department of Medical Oncology, Hematology and Infectious Diseases, Fukuoka University Hospital, Fukuoka, Japan.
  • Takano K; Department of Medical Oncology and Hematology, Faculty of Medicine, Oita University Hospital, Oita University, Oita, Japan.
  • Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.
  • Makita S; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
  • Taguchi J; Department of Hematology, Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki, Japan.
  • Gillings M; HUYABIO International, CEO, Corporate Office, San Diego, California, USA.
  • Onogi H; Research & Development, Huya Japan GK, Tokyo, Japan.
  • Tobinai K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Cancer Sci ; 113(8): 2778-2787, 2022 Aug.
Article em En | MEDLINE | ID: mdl-35579212
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Linfoma Folicular Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Leucemia-Linfoma de Células T do Adulto / Linfoma Folicular Tipo de estudo: Clinical_trials / Observational_studies Limite: Adult / Humans Idioma: En Revista: Cancer Sci Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão